Antibodies HPA002025 (Fig. 11A) and CAB014894 (Fig. 11B) directed against ERLIN2 suggested that ERLIN2 had low expression in PCa tissues; antibodies HPA022141 (Fig. 11C), HPA022882 (Fig. 11D), and HPA027883 (Fig. 11E) directed against CDK5RAP3 suggested that CDK5RAP3 was highly expressed in PCa tissues. Here, ERLIN2 is linked to posterior cortical atrophy.